Patents by Inventor Xiaoyi Ji

Xiaoyi Ji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selective CDK4/6 inhibitor and preparation thereof
    Patent number: 11485735
    Abstract: The present disclosure discloses a compound as represented by formula (I) or a pharmaceutically acceptable salt, a solvate or a stereoisomer thereof, that can be represented by the following structure As a selective inhibitor of cyclin-dependent kinase 4/6 (CDK4/6), the compounds of the present disclosure may be used for treating or preventing a disease at least partially modulated by CDK4/6.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: November 1, 2022
    Assignee: Wuxi Shuangliang Biotechnology Co., Ltd.
    Inventors: Jiaquan Wu, Feng Fan, Shuai Zhang, Zhenghua Lu, Chengchen Wang, Jian Dong, Jie Zhang, Teng Wang, Xiaoyi Ji, Minqi Gao
  • NOVEL SELECTIVE CDK4/6 INHIBITOR AND PREPARATION THEREOF
    Publication number: 20200339572
    Abstract: The present disclosure discloses a compound as represented by formula (I) or a pharmaceutically acceptable salt, a solvate or an isomer thereof, a pharmaceutical composition and a pharmaceutical preparation comprising the same, and the application thereof in the field of medicine. As a selective inhibitor of cyclin-dependent kinase 4/6 (CDK4/6), the compound of the present disclosure may be used for treating or preventing a disease at least partially modulated by CDK4/6, such as breast cancer and colon cancer.
    Type: Application
    Filed: April 13, 2020
    Publication date: October 29, 2020
    Applicant: Wuxi Shuangliang Biotechnology Co., Ltd.
    Inventors: Jiaquan Wu, Feng Fan, Shuai Zhang, Zhenghua Lu, Chengchen Wang, Jian Dong, Jie Zhang, Teng Wang, Xiaoyi Ji, Minqi Gao